@article{456f4957ea964655a2e8b9049202a3c5,
title = "Prolonged Treatment with Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL),",
author = "Andres Forero-Torres and Berryman, \{R. Brian\} and Advani, \{Ranjana H.\} and Bartlett, \{Nancy L.\} and Chen, \{Robert W.\} and Fanale, \{Michelle A.\} and Gopal, \{Ajay K.\} and O'Connor, \{Owen A.\} and Randal Olshefski and Smith, \{Scott E.\} and Grove, \{Laurie E.\} and Jeffrey Matous",
note = "624. Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster III | Andres Forero-Torres, R. Brian Berryman, Ranjana H. Advani, Nancy L. Bartlett, Robert W. Chen, Michelle A. Fanale, Ajay K. Gopal, Owen A. O'Connor, Randal Olshefski, Scott E. Smith, Laurie E.",
year = "2011",
month = nov,
day = "18",
doi = "10.1182/BLOOD.V118.21.3711.3711",
language = "American English",
volume = "118",
journal = "Blood",
publisher = "American Society of Hematology",
number = "21",
}